Nonbenzodiazepine hypnotic, Lunesta (eszopiclone) now marketed in Canada Approved for short-term use in adults with difficulty falling asleep, or nocturnal or early morning awakenings. Rx Q&A: Trintellix for improved function in patients with major depressive disorder Provide families with guidance on how to reset sleep times disrupted by COVID-19 Pandemic has significantly altered normal sleep patterns for children and teenagers Spravato, a new intranasal treatment for resistant depression Intended for patients who have not responded adequately to at least two different antidepressants Scientists get closer to blood test for Alzheimer's disease The testing identified people with Alzheimer's vs. no dementia or other types of it with accuracy ranging from 89% to 98% Consider long-acting injectable antipsychotics more often in early-phase schizophrenia Study reports significant delay in time to hospitalization compared to usual care when LAIAs are used in patients with early-phase schizophrenia Q&A: Antidepressants now Psychiatrist Dr. Jon Davine’s advice for FPs on optimizing antidepressant dose, switching and augmenting Overdiagnosed, overtreated For decades psychiatrists have argued over the boundaries between pathology and normality. Are we any closer to an answer? Beyond the baby blues How pharmacists can help women struggling with postpartum depression Mortality in patients prescribed hypnotics/anxiolytics Mortality of multimorbid patients who did not use the drugs was approximately 14% higher than in patients who were neither multimorbid nor using the drugs First Previous 20 21 22 23 24 Next Last
